The BECN1 Knockout Ca Ski Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from Ca Ski cervical carcinoma cells, engineered for targeted disruption of the BECN1 gene. This loss-of-function model eliminates Beclin-1 protein expression across a heterogeneous cell pool, providing a physiologically relevant system to study autophagy defects without clonal selection artifacts. The polyclonal format preserves population-level biological variability while ensuring robust loss of Beclin-1-dependent functions, making it suitable for reproducible pathway analysis and drug response profiling.
Ca Ski cells are an adherent epithelial-like cell line originally isolated from a cervical epidermoid carcinoma metastasis and are persistently infected with human papillomavirus type 16 (HPV16). As an HPV16-positive model, these cells constitutively express the viral oncoproteins E6 and E7, which target p53 and pRb tumor suppressors for degradation, driving uncontrolled proliferation and genomic instability. This genetic background recapitulates key features of HPV-driven cervical carcinogenesis and provides a clinically relevant platform for investigating autophagy?Ccancer interactions in a virally transformed context.
BECN1 encodes Beclin-1, a core scaffold protein of the class III phosphatidylinositol 3-kinase (PI3K-III) complex. Beclin-1 interacts directly with PIK3C3/VPS34, ATG14, UVRAG, and AMBRA1 to form the autophagy-initiating complex, while its activity is modulated by binding partners including BCL2, BCL-XL, Rubicon, and VMP1. Upstream signals from ULK1, AMPK, and death receptors (FAS, TNFRSF) activate Beclin-1, whereas mTOR and BCL2 inhibit it. Downstream, Beclin-1-directed PI3P synthesis on phagophore membranes triggers LC3 lipidation, p62/SQSTM1 degradation, autophagic flux, and endosome maturation, thereby integrating nutrient sensing, stress responses, and programmed cell death.
In the HPV16-positive Ca Ski background, BECN1 knockout disrupts canonical autophagy and may alter sensitivity to metabolic stress, chemotherapeutics, and immune surveillance. Given Beclin-1??s established role as a tumor suppressor??frequently monoallelically lost in breast, ovarian, and cervical cancers??this model enables dissection of autophagy-dependent versus autophagy-independent effects on HPV-mediated transformation. It also permits examination of crosstalk between Beclin-1 loss and E6/E7-driven pathways, including potential modulation of p53-dependent apoptosis and cellular senescence.
Researchers can employ this polyclonal knockout population for a wide range of autophagy-focused assays: immunofluorescence analysis of LC3 puncta, western blotting for LC3-II and p62 turnover, and autophagic flux measurements using bafilomycin A1. The cells support co-immunoprecipitation of PI3K-III components, RT-qPCR quantification of HPV E6/E7 expression, cell viability assays under nutrient deprivation, and in vivo xenograft tumor growth studies. Additional applications extend to drug resistance screening in cervical cancer, investigation of Beclin-1 in innate immunity and inflammatory bowel disease, and vaccine development. For further technical information, please contact Ascent Research.
